Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.

• Status: Not yet recruiting
• Trial end date: 2022-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Our primary objective is to assess the effect of Liraglutide on weight loss in patients who have undergone secondary bariatric surgeries. We set out to assess if Liraglutide is a viable option to augment weight loss in said category.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: General Committee of Teaching Hospitals and Institutes, Egypt
• Treatments: Liraglutide

Criteria

Inclusion Criteria:

• Undergone primary bariatric surgery

• Need secondary bariatric surgery due to either weight regain (regained weight to have BMI > 35) or medical associated diseases

Exclusion Criteria:

• Prior use of GLP-1 agonist

• Past history of pancreatitis

• Personal or family history of medullary thyroid cancer

• Pregnancy or lactation

• Acute coronary syndrome

• Hepatic or renal dysfunction

• Active malignancy